US20060078997A1 - Methods for altering surface characteristics of microspheres - Google Patents
Methods for altering surface characteristics of microspheres Download PDFInfo
- Publication number
- US20060078997A1 US20060078997A1 US11/247,943 US24794305A US2006078997A1 US 20060078997 A1 US20060078997 A1 US 20060078997A1 US 24794305 A US24794305 A US 24794305A US 2006078997 A1 US2006078997 A1 US 2006078997A1
- Authority
- US
- United States
- Prior art keywords
- microsphere
- enolic acid
- acid
- enolic
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 266
- 238000000034 method Methods 0.000 title claims abstract description 73
- 239000002253 acid Substances 0.000 claims abstract description 186
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 60
- 229920000642 polymer Polymers 0.000 claims abstract description 31
- 238000005859 coupling reaction Methods 0.000 claims abstract description 29
- 238000010168 coupling process Methods 0.000 claims abstract description 28
- 230000008878 coupling Effects 0.000 claims abstract description 27
- 238000003556 assay Methods 0.000 claims abstract description 18
- 125000000524 functional group Chemical group 0.000 claims description 35
- 239000000178 monomer Substances 0.000 claims description 24
- 125000003636 chemical group Chemical group 0.000 claims description 23
- MDYOLVRUBBJPFM-UHFFFAOYSA-N Tropolone Natural products OC1=CC=CC=CC1=O MDYOLVRUBBJPFM-UHFFFAOYSA-N 0.000 claims description 14
- PWEBUXCTKOWPCW-UHFFFAOYSA-N squaric acid Chemical compound OC1=C(O)C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-N 0.000 claims description 14
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 13
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 12
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims description 10
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 claims description 10
- -1 hydroxy tropolone Chemical class 0.000 claims description 9
- 235000012239 silicon dioxide Nutrition 0.000 claims description 9
- 230000003213 activating effect Effects 0.000 claims description 8
- 125000001174 sulfone group Chemical group 0.000 claims description 8
- VBKKVDGJXVOLNE-UHFFFAOYSA-N Dioxation Chemical compound CCOP(=S)(OCC)SC1OCCOC1SP(=S)(OCC)OCC VBKKVDGJXVOLNE-UHFFFAOYSA-N 0.000 claims description 6
- RBSLJAJQOVYTRQ-UHFFFAOYSA-N croconic acid Chemical compound OC1=C(O)C(=O)C(=O)C1=O RBSLJAJQOVYTRQ-UHFFFAOYSA-N 0.000 claims description 6
- 150000007973 cyanuric acids Chemical class 0.000 claims description 6
- WCJLIWFWHPOTAC-UHFFFAOYSA-N rhodizonic acid Chemical compound OC1=C(O)C(=O)C(=O)C(=O)C1=O WCJLIWFWHPOTAC-UHFFFAOYSA-N 0.000 claims description 6
- JZADFTZEYJKJDG-UHFFFAOYSA-N CN1CCOCC1.COC1=CC(=NN=N1)OC Chemical compound CN1CCOCC1.COC1=CC(=NN=N1)OC JZADFTZEYJKJDG-UHFFFAOYSA-N 0.000 claims description 5
- 150000001642 boronic acid derivatives Chemical class 0.000 claims description 5
- 238000007334 copolymerization reaction Methods 0.000 claims description 4
- 238000001514 detection method Methods 0.000 description 36
- 150000007513 acids Chemical class 0.000 description 25
- 239000003607 modifier Substances 0.000 description 25
- 0 *C1=C(O)C(=O)C1=O Chemical compound *C1=C(O)C(=O)C1=O 0.000 description 23
- 239000007787 solid Substances 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 16
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000000975 dye Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 10
- 230000021615 conjugation Effects 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- GVJXGCIPWAVXJP-UHFFFAOYSA-N 2,5-dioxo-1-oxoniopyrrolidine-3-sulfonate Chemical compound ON1C(=O)CC(S(O)(=O)=O)C1=O GVJXGCIPWAVXJP-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 150000003457 sulfones Chemical class 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000005286 illumination Methods 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 229920002554 vinyl polymer Polymers 0.000 description 6
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical class [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000007806 chemical reaction intermediate Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 125000005647 linker group Chemical group 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- SJJUTRFFONLOHZ-UHFFFAOYSA-N 5-amino-2-hydroxycyclohepta-2,4,6-trien-1-one Chemical compound NC1=CC=C(O)C(=O)C=C1 SJJUTRFFONLOHZ-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000004566 IR spectroscopy Methods 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- CSFWPUWCSPOLJW-UHFFFAOYSA-N lawsone Chemical compound C1=CC=C2C(=O)C(O)=CC(=O)C2=C1 CSFWPUWCSPOLJW-UHFFFAOYSA-N 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 230000003595 spectral effect Effects 0.000 description 4
- 150000004788 tropolones Chemical class 0.000 description 4
- HZXQUMNXGUKGCC-UHFFFAOYSA-N 2-chloro-4,6-bis(2-methoxyethoxy)-1,3,5-triazine Chemical compound COCCOC1=NC(Cl)=NC(OCCOC)=N1 HZXQUMNXGUKGCC-UHFFFAOYSA-N 0.000 description 3
- FYTNKOSUJSUKML-UHFFFAOYSA-N 2-hydroxy-5-nitrosocyclohepta-2,4,6-trien-1-one Chemical compound OC1=CC=C(N=O)C=CC1=O FYTNKOSUJSUKML-UHFFFAOYSA-N 0.000 description 3
- 239000004971 Cross linker Substances 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000004166 bioassay Methods 0.000 description 3
- 125000005620 boronic acid group Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 3
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000269 nucleophilic effect Effects 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- LYEDSWACEOBISX-UHFFFAOYSA-M 4-[4,6-bis(2-methoxyethoxy)-1,3,5-triazin-2-yl]-4-methylmorpholin-4-ium;chloride Chemical compound [Cl-].COCCOC1=NC(OCCOC)=NC([N+]2(C)CCOCC2)=N1 LYEDSWACEOBISX-UHFFFAOYSA-M 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000010668 complexation reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-N mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 2
- DXBWLZYZDIQTAE-UHFFFAOYSA-N n-[2-[[4-chloro-6-[2-[di(propan-2-yl)amino]ethoxy]-1,3,5-triazin-2-yl]oxy]ethyl]-n-propan-2-ylpropan-2-amine Chemical compound CC(C)N(C(C)C)CCOC1=NC(Cl)=NC(OCCN(C(C)C)C(C)C)=N1 DXBWLZYZDIQTAE-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000005588 protonation Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000010532 solid phase synthesis reaction Methods 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 150000003918 triazines Chemical class 0.000 description 2
- 150000000185 1,3-diols Chemical group 0.000 description 1
- ZWXDAANEJMSCEX-UHFFFAOYSA-N 1-(3-anilinophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(NC=2C=CC=CC=2)=C1 ZWXDAANEJMSCEX-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- QXYLYYZZWZQACI-UHFFFAOYSA-N 2,3,4,5-tetrafluorophenol Chemical compound OC1=CC(F)=C(F)C(F)=C1F QXYLYYZZWZQACI-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical class C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- FPENCTDAQQQKNY-UHFFFAOYSA-N 3,4-difluorobenzoic acid Chemical compound OC(=O)C1=CC=C(F)C(F)=C1 FPENCTDAQQQKNY-UHFFFAOYSA-N 0.000 description 1
- YDTMEWBWUSIGQW-UHFFFAOYSA-N 3-ethenyl-4-hydroxycyclobut-3-ene-1,2-dione Chemical compound OC1=C(C=C)C(=O)C1=O YDTMEWBWUSIGQW-UHFFFAOYSA-N 0.000 description 1
- HXLJFMRZKCSTQD-UHFFFAOYSA-N 3-oxoindane-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)CC(=O)C2=C1 HXLJFMRZKCSTQD-UHFFFAOYSA-N 0.000 description 1
- DCHSBPLKXWBLIT-UHFFFAOYSA-N 4-bromo-2,3-dihydroxybenzoic acid Chemical class OC(=O)C1=CC=C(Br)C(O)=C1O DCHSBPLKXWBLIT-UHFFFAOYSA-N 0.000 description 1
- 108010031480 Artificial Receptors Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- AUGRWHYFYOLGPK-UHFFFAOYSA-N C.C.C.CC(=O)O.CC(=O)O.CC(=O)OC1C(=O)CC(S(=O)(=O)O)C1=O.CC(C)=O.COC1=NC(OC)=NC(OC(C)=O)=N1.COC1=NC(OC)=NC([N+]2(C)CCCCC2)=N1.[Cl-] Chemical compound C.C.C.CC(=O)O.CC(=O)O.CC(=O)OC1C(=O)CC(S(=O)(=O)O)C1=O.CC(C)=O.COC1=NC(OC)=NC(OC(C)=O)=N1.COC1=NC(OC)=NC([N+]2(C)CCCCC2)=N1.[Cl-] AUGRWHYFYOLGPK-UHFFFAOYSA-N 0.000 description 1
- BWLFCLSVKRBYFV-UHFFFAOYSA-N C=CC.C=CC1=CC=C([Si](O)(O)O)C=C1.O=C1C=CC=CC=C1O Chemical compound C=CC.C=CC1=CC=C([Si](O)(O)O)C=C1.O=C1C=CC=CC=C1O BWLFCLSVKRBYFV-UHFFFAOYSA-N 0.000 description 1
- JZFVZCUMSCZPCH-UHFFFAOYSA-N C=CC1=C(O)C(=O)C1=O.C=CC1=CC=C(C2=C(O)C(=O)C2=O)C=C1 Chemical compound C=CC1=C(O)C(=O)C1=O.C=CC1=CC=C(C2=C(O)C(=O)C2=O)C=C1 JZFVZCUMSCZPCH-UHFFFAOYSA-N 0.000 description 1
- SQNXRRDFBPSWCD-UHFFFAOYSA-N C=CC1=CC=C(C)C=C1.CC(C)CC1=CC([N+](=O)[O-])=C(O)C=C1 Chemical compound C=CC1=CC=C(C)C=C1.CC(C)CC1=CC([N+](=O)[O-])=C(O)C=C1 SQNXRRDFBPSWCD-UHFFFAOYSA-N 0.000 description 1
- RYVTTXXLITYVHO-UHFFFAOYSA-K CC(=O)NC1=CC=C(O)C(=O)C=C1.CC(=O)O.CCO.Cl[Sn]Cl.NC1=CC=C(O)C(=O)C=C1.O=C1C=CC=CC=C1O.O=NC1=CC=C(O)C(=O)C=C1.O=NO[Na] Chemical compound CC(=O)NC1=CC=C(O)C(=O)C=C1.CC(=O)O.CCO.Cl[Sn]Cl.NC1=CC=C(O)C(=O)C=C1.O=C1C=CC=CC=C1O.O=NC1=CC=C(O)C(=O)C=C1.O=NO[Na] RYVTTXXLITYVHO-UHFFFAOYSA-K 0.000 description 1
- ASONKWVRLAXTGG-UHFFFAOYSA-N CC(C)C1=OCOC=C1 Chemical compound CC(C)C1=OCOC=C1 ASONKWVRLAXTGG-UHFFFAOYSA-N 0.000 description 1
- WHCMBWZDZYHTPE-UHFFFAOYSA-N COC1=NC(Cl)=NC(OC)=N1.COC1=NC(OC)=NC([N+]2(C)CCOCC2)=N1.ClC1=NC(Cl)=NC(Cl)=N1.[Cl-] Chemical compound COC1=NC(Cl)=NC(OC)=N1.COC1=NC(OC)=NC([N+]2(C)CCOCC2)=N1.ClC1=NC(Cl)=NC(Cl)=N1.[Cl-] WHCMBWZDZYHTPE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000551547 Dione <red algae> Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical group F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229910006069 SO3H Chemical group 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000007825 activation reagent Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001265 acyl fluorides Chemical class 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001718 carbodiimides Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- IPPWILKGXFOXHO-UHFFFAOYSA-N chloranilic acid Chemical compound OC1=C(Cl)C(=O)C(O)=C(Cl)C1=O IPPWILKGXFOXHO-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical compound O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 150000002691 malonic acids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229940112801 mobic Drugs 0.000 description 1
- KGPQKNJSZNXOPV-UHFFFAOYSA-N moniliformin Chemical compound OC1=CC(=O)C1=O KGPQKNJSZNXOPV-UHFFFAOYSA-N 0.000 description 1
- ZYWUVGFIXPNBDL-UHFFFAOYSA-N n,n-diisopropylaminoethanol Chemical compound CC(C)N(C(C)C)CCO ZYWUVGFIXPNBDL-UHFFFAOYSA-N 0.000 description 1
- COCAUCFPFHUGAA-MGNBDDOMSA-N n-[3-[(1s,7s)-5-amino-4-thia-6-azabicyclo[5.1.0]oct-5-en-7-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide Chemical compound C=1C=C(F)C([C@@]23N=C(SCC[C@@H]2C3)N)=CC=1NC(=O)C1=CC=C(Cl)C=N1 COCAUCFPFHUGAA-MGNBDDOMSA-N 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical group [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical group 0.000 description 1
- 239000000985 reactive dye Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- QYHFIVBSNOWOCQ-UHFFFAOYSA-N selenic acid Chemical compound O[Se](O)(=O)=O QYHFIVBSNOWOCQ-UHFFFAOYSA-N 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000005624 silicic acid group Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- PWEBUXCTKOWPCW-UHFFFAOYSA-L squarate Chemical compound [O-]C1=C([O-])C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-L 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical group [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003462 sulfoxides Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000979 synthetic dye Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- FDRPZJWMPZUHBN-UHFFFAOYSA-N triazin-2-ium;chloride Chemical class Cl.C1=CN=NN=C1 FDRPZJWMPZUHBN-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
- G01N33/546—Synthetic resin as water suspendable particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6417—Spectrofluorimetric devices
- G01N2021/6421—Measuring at two or more wavelengths
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2650/00—Assays involving polymers whose constituent monomers bore biological functional groups before polymerization, i.e. vinyl, acryl derivatives of amino acids, sugars
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/13—Tracers or tags
Definitions
- the immobilization of biomolecules or any other such entities can be achieved by coupling by (a) ionic interactions; (b) adsorption; (c) complexation (e.g. “metal-coordination” mediated coupling); and (d) covalent bond formation between active/stable reactive groups on the surface and specific functional groups on the entity to be immobilized.
- particles e.g., micro- and nano-spheres; nanotubes; metal particles including one or more metals with any size, shape, or composition; semiconductor particles; molecularly imprinted polymers (MIPS); magnetic particles; and other dyed materials
- microtiter plates are common solid matrices in many immobilization systems.
- the reaction intermediate has an extremely short half-life and rapidly undergoes hydrolysis or rearranges to produce the N-acylurea adduct.
- the optimum pH for the formation of O-acylurea is about 4-5.
- the primary amino group of the nucleophile is predominantly protonated at a pH of about 4-5 and is thus mostly unreactive.
- These limitations of the reaction intermediate can severely restrict coupling yields of biomolecules to microspheres.
- nucleic acid bases of a biomolecule may undergo intensive protonation. Such protonation induces DNA melting that exposes the hydrophobic core of the helix thereby facilitating nonspecific hydrophobic interactions of the helix with the solid matrix of the micro spheres.
- EDC-mediated coupling is currently the major mode of covalent immobilization of biomolecules to solid surfaces as described by Hermanson, G. T., in Bioconjugate Techniques , Academic Press, NY, 1996; Frey, A. et al., Bioconjugate Chem., 1999, 10, 562-571; Gilles, M. A. et al., Anal. Biochem., 1990, 184, 244-248; Chan V. W. F. et al., Biochem. Biophys. Res. Communications, 1988, 151(2), 709-716; and Valuev, I. L. et al., Biomaterials, 1998, 19, 41-43, which are all incorporated by reference as if fully set forth herein.
- Acidic functional groups have also been added to glass surfaces as described by, for example, Geiger, F. M. et al., J. Am. Chem. Soc., 2004, 126, 11754, which is incorporated by reference as if fully set forth herein.
- One embodiment relates to a method for altering surface characteristics of a microsphere.
- the method includes coupling an enolic acid to the microsphere to modify the surface characteristics of the microsphere.
- the enolic acid may include one or more enolic acid molecules coupled to different locations on the microsphere.
- a reagent can be coupled to the microsphere via the enolic acid.
- the enolic acid may be replaced with an enolic acid derivative or a mixed functional group.
- the enolic acid may be more generally represented as an ionizable polar group that is in conjugation with a chemical group.
- the chemical group may include, for example, a sulfone group or a carbonyl group.
- the enolic acid contains at least one hydrophilic group.
- the enolic acid may include a deltic, squaric, croconic, or rhodizonic acid, or other homolog.
- the enolic acid may include 5-substituted hydroxy tropolone.
- the enolic acid may include a cyanuric acid or a cyanuric acid derivative.
- the enolic acid may include dimethoxy triazine methylmorpholine modified to contain hydrophilic groups.
- the enolic acid may include a mixed functional group.
- the mixed functional group may include a boronic acid or a boronic acid derivative.
- the enolic acid may include a silicic acid or a silicic acid derivative.
- coupling the enolic acid to the microsphere may include copolymerizing a monomer containing a vinyl group and the enolic acid with a different monomer to form the microsphere having the modified surface characteristics.
- coupling the enolic acid to the microsphere may include attaching the enolic acid to a surface of the microsphere.
- the modified surface characteristics may increase a stability of the reagent when the reagent is coupled to the microsphere.
- the modified surface characteristics may also improve performance of an assay carried out with the microsphere.
- the reagent may include, for example, a biomolecule.
- the enolic acid may be coupled to the polymer core via copolymerization using a monomer containing a vinyl group and the enolic acid with a different monomer.
- the enolic acid may be coupled to the polymer core via attachment of the enolic acid to a surface of the polymer core.
- FIG. 1 is a schematic diagram illustrating one example of a measurement system that may be used to perform experiments using embodiments of microspheres described herein.
- the term “reagent” generally refers to a molecule that is coupled to a microsphere such that the reagent can react with an analyte during an assay or other experiment performed using the microsphere.
- appropriate reagents include, but are not limited to, biomolecules such as proteins, nucleotides, oligonucleotides, enzymes, antigens, antibodies, or any other molecule involved in or related to biological functioning of a human, animal, plant, etc., drug candidates, and dyes.
- Vinyl containing monomers such as 3-hydroxy-4-(4-styryl)-3-cyclobutene-1,2-dione can be prepared by an extension of a general method reported in the literature by Meier, H. et al., Tetrahedron Lett. 1996, 37(8), 1191, which is incorporated by reference as if fully set forth herein.
- This functional monomer can be used to couple enolic acid groups to the surface of microspheres during polymerization.
- Vinyl enolic acids such as 3-hydroxy-4-vinyl-3-cyclobutene-1,2-dione have been reported by Sprenger, H. E. et al., Angew. Chem. Int. Ed. Engl., 1968, 7, 530, which is incorporated by reference as if fully set forth herein.
- enolic acids that may be used in the methods described herein include cyanuric acid and its derivatives, boronic acid and its derivatives, silicic acids and their derivatives, and other enolic acids and their derivatives.
- Cyanuric acid and derivatives thereof include compounds that can be represented by the general formula shown in Table 1, Entry 2.
- Resins activated with cyanuric chloride and resin bound triazine used to activate carboxyl groups for nucleophilic substitution at the carboxyl groups to produce amides are described by Venkataraman, K. et al., Tetrahedron Lett., 1979, 32, 3037, which is incorporated by reference as if fully set forth herein
- Luminol Hydrazide derivatives such as Luminol (Table 1, entry 8) exhibit ionizable OH groups and can be immobilized on a microsphere surface using an amino group. Compounds like Luminol have been used for chemiluminescence analysis.
- IR spectroscopy of the product identified the following characteristic IR absorption frequencies: 1605 cm ⁇ 1 , 1417 cm ⁇ 1 , 1336 cm ⁇ 1 , 1300 cm ⁇ 1 , 1118 cm ⁇ 1 , 1094 cm ⁇ 1 , 1068 cm ⁇ 1 , 1053 cm ⁇ 1 , 1028 cm ⁇ 1 , 1009 cm '1 , 991 cm ⁇ 1 , 972 cm ⁇ 1 , 858 cm ⁇ 1 , and 821 cm ⁇ 1 .
- the measurement system is shown along a plane through the cross-section of cuvette 12 through which microspheres 10 flow.
- the cuvette may be a standard quartz cuvette such as that used in standard flow cytometers. Any other suitable type of viewing or delivery chamber, however, may also be used to deliver the sample for analysis.
- Microspheres 10 may be formed according to the embodiments described herein.
- Light scattered and/or emitted by the microspheres at an angle of about 90 degrees from the direction of illumination by the light source may also be collected.
- this scattered light may be separated into more than one beam of light by one or more beamsplitters or dichroic mirrors.
- light scattered at an angle of about 90 degrees to the direction of illumination may be separated into two different beams of light by beamsplitter 20 .
- the two different beams of light may be separated again by beamsplitters 22 and 24 to produce four different beams of light.
- Each of the beams of light may be directed to a different detection system, which may include one or more detectors.
- one of the four beams of light may be directed to detection system 26 .
- Detection system 26 may be configured to detect light scattered by the microspheres.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
- This application claims priority to U.S. Provisional Application No. 60/618,338 entitled “Methods for Altering Surface Characteristics of Microspheres,” filed Oct. 12, 2004, which is incorporated by reference as if fully set forth herein.
- 1. Field of the Invention
- This invention generally relates to methods for altering surface characteristics of microspheres. Certain embodiments include coupling an enolic acid to the microsphere to modify the surface characteristics of the microsphere such that a reagent can be coupled to the microsphere via the enolic acid.
- 2. Description of the Related Art
- The following descriptions and examples are not admitted to be prior art by virtue of their inclusion within this section.
- Spectroscopic techniques are widely employed in the analysis of chemical and biological systems. Most often, these techniques involve measuring the absorption or emission of electromagnetic radiation by the material of interest. One such application is in the field of microarrays, which is a technology exploited by a large number of disciplines including the combinatorial chemistry and biological assay industries. One company, Luminex Corporation of Austin, Tex., has developed a system in which biological assays are performed on the surface of variously colored fluorescent microspheres. One example of such a system is illustrated in U.S. Pat. No. 5,981,180 to Chandler et al., which is incorporated by reference as if fully set forth herein. In such a fluid flow device, microspheres are interrogated by laser excitation and fluorescence detection of each individual microsphere as it passes at relatively high speed through a detection zone. Measurement data generated by such a system may be easily exported to a database for further analysis.
- Assays based on fluorescent microspheres for multiplexed analysis have been also reported by several groups and individuals as described by Fulton et al., Clin. Chem., 1997, 43, 1749-1756; Kettman et al., Cytometry, 1998, 33, 234-243; McDade et al., Med. Dev. Diag. Indust., 1997, 19(4), 75-82; McHugh, Methods Cell Biol., 1994, 42, 575-595; and Nikiforov et al., Nucleic Acid Res., 1994, 22, 4167-4175; and U.S. Pat. No. 5,736,330 to Fulton, U.S. Pat. No. 6,046,807 to Chandler, U.S. Pat. No. 6,057,107 to Fulton, U.S. Pat. No. 6,139,800 to Chandler, U.S. Pat. No. 6,268,222 to Chandler et al., U.S. Pat. No. 6,366,354 to Chandler, U.S. Pat. No. 6,411,904 to Chandler, and U.S. Pat. No. 6,449,562 to Chandler et al., which are incorporated by reference as if fully set forth herein.
- In the above-mentioned systems, fluorescent dyes are absorbed into the microspheres and/or bound to the surface of the microspheres. The dyes are chosen based on their ability to emit light in the wavelength of a chosen detection window of the system. Further, the detection windows are spaced apart by a number of wavelengths, and the dyes are designed to minimize the overlap of a dye's fluorescent signal within adjacent detection windows. By employing two detection windows and two dyes, each at 10 different concentrations, there would thus be 100 fluorescently distinguishable microsphere sets.
- In the last three decades, advancements in the fields of affinity chromatography, solid-phase synthesis, and immobilization of bio-macromolecules, such as proteins, oligonucleotides and the like, have led to microsphere-based biomedical applications. For example, one or more biomolecules may be bound to the surface of microspheres. The one or more biomolecules are selected based on the specific assay to be carried out. For example, one population of microspheres may include different subsets of microspheres, each coupled to a different antigen. The subsets may be combined with a sample, and the assay may be performed to determine which antibodies are present in the sample. The biomolecule(s) that are bound to the microspheres may include any biomolecules known in the art.
- The immobilization of biomolecules or any other such entities can be achieved by coupling by (a) ionic interactions; (b) adsorption; (c) complexation (e.g. “metal-coordination” mediated coupling); and (d) covalent bond formation between active/stable reactive groups on the surface and specific functional groups on the entity to be immobilized. For example, particles (e.g., micro- and nano-spheres; nanotubes; metal particles including one or more metals with any size, shape, or composition; semiconductor particles; molecularly imprinted polymers (MIPS); magnetic particles; and other dyed materials) and microtiter plates are common solid matrices in many immobilization systems. Preparing and maintaining the active, functionalized surface of the solids are important to assure immobilization of biological material for development of a sufficiently sensitive assay. Current procedures for immobilization of biomolecules on solid surfaces generally involve reactions of activated carboxyl, amino-, hydroxyl- or thiol-groups on the solid surfaces with the biomolecules. After activation of, or introduction of a functionalized spacer to, these groups, the activated groups provide sites on the solid surface for direct attachment of the biomolecules.
- Currently used groups for providing direct attachment sites, however, have a number of disadvantages. For example, most of these functional groups (such as N-hydroxysuccinimide (NHS) esters, isothiocyanates, etc.) are prone to hydrolysis in an aqueous environment and become non-reactive (i.e., chemically inactive) in a matter of less than an hour. Therefore, such functional groups may undesirably exhibit time-dependent variations in the quantity, repeatability, and uniformity with which biomolecules may be attached to the surface of solids using these functional groups.
- Reactive or functionalized microspheres are conventionally produced via copolymerization of suitably functionalized monomers or via chemical modification of preformed microspheres. Post-functionalization is a popular method for preparing reactive particles as earlier described by Upson, (J. Polym. Sci., Polym. Symp., 1985, 72, 45, which is incorporated by reference as if fully set forth herein.
- More recent work on the production and evaluation of a variety of tailor-made particles has been reported by several groups including Margel, et al., (J. Polym. Sci., 1991, A-29, 347-355; Anal. Biochem., 1981, 128, 342-350), Ugelstad et al., (Makromol. Chem., 1979, 180, 737-744; Adv. Colloid Interface Sci., 1980, 13, 102-140), and Rembaum et al. (Br. Polym. J., 1978, 10, 275-280; J. Macromol. Sci. Chem., 1979, A-13, 603-632), which are incorporated by reference as if fully set forth herein. A review by R. Arshady, Biomaterials, 1993, 14, 5-15, which is also incorporated by reference as if fully set forth herein, describes the synthesis and physico-chemical properties of reactive and labeled microspheres.
- Fray et al., Bioconjugate Chem., 1999, 10, 562-571, which is incorporated by reference as if fully set forth herein, have reported a strategy in which particles are pre-activated with hydrolysis-resistant aldehyde functional groups, but low reaction yields of less than 8% have been observed with these microspheres. U.S. Pat. No. 6,146,833 to Milton, which is incorporated by reference as if fully set forth herein, describes a reaction between an acyl fluoride activated polymer-surface and an amino derivatized biomolecule at room temperature. The use of fluorophenyl resins in the solid phase synthesis of amides, peptides, hydroxamic acids, amines, urethanes, carbonates, sulfonamides, and alpha-substituted carbonyl compounds has been described in International Publication No. WO 99/67228 to Clerc et al., which is incorporated by reference as if fully set forth herein.
- Medvedkin et al., Bioorg. Khirn., 1995, 21(9), 684-690, which is incorporated by reference as if fully set forth herein, illustrates using sulfo-tetrafluorophenyl activated esters in peptide synthesis and demonstrates their reactivity combined with good stability under aqueous storage conditions. Apparently, the pre-activation of a polystyrene surface with this reagent has not yet been reported.
- Hoechst, in German Patent No. DE 960,534 to Heyna et al., which is incorporated by reference as if fully set forth herein, claimed the use of reactive vinyl sulfone (VS)-modified dyes for dyeing of cellulose and wool fibers in 1950. A review by Siegel provides a complete account of reactive dyes based on VS and its protected 2-sulfatoethyl and 2-thiosulfatoethyl sulfones (E. Siegel in The Chemistry of Synthetic Dyes, Vol. VI, (Ed. K Venkataraman); 2-108, Academic Press, 1972, which is incorporated by reference as if fully set forth herein). U.S. Pat. No. 5,414,135 to Snow et al., which is incorporated by reference as if fully set forth herein, describes modification of proteins with PEG-supported VS.
- The most frequently used method to immobilize biomolecules (such as oligonucleotides, proteins, and carbohydrates) onto fluorescent microspheres is by activating carboxy groups present on the surface of the microspheres. The activation requires excess N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide (EDC) and a coupling pH of 4 to 6. The reaction between the carbodiimide and carboxyl functional groups forms an activated O-acylurea derivative reaction intermediate. A subsequent nucleophilic attack of the reaction intermediate by the primary nitrogen of the amino-groups of the biomolecule being attached to the microspheres releases the substituted urea and produces an amide linkage between the reaction intermediate and the biomolecule.
- There are, however, a number of disadvantages to such activation of the carboxy groups. For example, the reaction intermediate has an extremely short half-life and rapidly undergoes hydrolysis or rearranges to produce the N-acylurea adduct. In addition, the optimum pH for the formation of O-acylurea is about 4-5. However, the primary amino group of the nucleophile is predominantly protonated at a pH of about 4-5 and is thus mostly unreactive. These limitations of the reaction intermediate can severely restrict coupling yields of biomolecules to microspheres. Furthermore, at low pH, nucleic acid bases of a biomolecule may undergo intensive protonation. Such protonation induces DNA melting that exposes the hydrophobic core of the helix thereby facilitating nonspecific hydrophobic interactions of the helix with the solid matrix of the micro spheres.
- Despite these drawbacks, EDC-mediated coupling is currently the major mode of covalent immobilization of biomolecules to solid surfaces as described by Hermanson, G. T., in Bioconjugate Techniques, Academic Press, NY, 1996; Frey, A. et al., Bioconjugate Chem., 1999, 10, 562-571; Gilles, M. A. et al., Anal. Biochem., 1990, 184, 244-248; Chan V. W. F. et al., Biochem. Biophys. Res. Communications, 1988, 151(2), 709-716; and Valuev, I. L. et al., Biomaterials, 1998, 19, 41-43, which are all incorporated by reference as if fully set forth herein.
- For combinatorial libraries, building blocks such as malonic acids, dihydroxy benzoic acid, hydroxy phenyl acetic acid, pyroline carboxylic acids, bromodihydroxy benzoic acids, 3-oxo-1-indancarboxylic acid, 3-nitrophenyl acetic acid, and 3,4-difluoro benzoic acid have been reported by, for example, Lin, R. et al., in J. Am. Chem. Soc., 2002, 124, 7678-7680, which is incorporated by reference as if fully set forth herein.
- Some molecules that can be incorporated into polymers to modify the surface characteristics of the polymers have been reported and are shown below.
Organic reactions using polymer supported catalysts, reagents or substrates are known as described by, for example, Hodge, P. in “Synthesis and separations using functional polymers,” Editors, Sherrington, D. C. & Hodge, P., 1988, John Wiley, 44-113, which is incorporated by reference as if fully set forth herein. - Polymer supported phenolic compounds are known. For example, polymer supported tetrafluoro phenol is now used as an activated resin for chemical library synthesis as described by Salvino, J. M. et al., J. Comb. Chem., 2000, 2, 691-699, which is incorporated by reference as if fully set forth herein.
- Boronic acid is routinely incorporated into synthetic receptors for the complexation of saccharides and other guests that possess 1,2 and 1,3 diol functionality, as described by Czarnik, A. W. et al., J. Am. Chem. Soc. 1992, 114, 5874, Shinkai, S. J., J. Chem. Soc. Chem. Commun., 1994, 477, and Geert-Jan Boons et al., Tetrahedron Lett., 200, 41, 6965, which are incorporated by reference as if fully set forth herein. Boronic acids have also been incorporated into a chemical affinity system for the purification of proteins, as described by Bergseid, M. et al., in Biotechniques, 2000, 29, 1126, which is incorporated by reference as if fully set forth herein. The use of various boronic acids to link two entities together has been disclosed in U.S. Pat. No. 6,008,406 to Stolowitz, U.S. Pat. No. 6,075,126 to Stolowitz et al., U.S. Pat. No. 6,124,471 to Stolowitz et al., U.S. Pat. No. 6,462,179 to Stolowitz et al., and U.S. Pat. No. 6,630,577 to Stolowitz et al., which are incorporated by reference as if fully set forth herein.
- Acidic functional groups have also been added to glass surfaces as described by, for example, Geiger, F. M. et al., J. Am. Chem. Soc., 2004, 126, 11754, which is incorporated by reference as if fully set forth herein.
- Accordingly, it would be advantageous to develop a method for altering the surface characteristics of a microsphere without one or more of the disadvantages described above such as time-dependent variations in the attachment of biomolecules to the surface of microspheres due to hydrolysis of the functional groups used to attach the biomolecules.
- The following description of various method, microsphere, and kit embodiments is not to be construed in any way as limiting the subject matter of the appended claims.
- One embodiment relates to a method for altering surface characteristics of a microsphere. The method includes coupling an enolic acid to the microsphere to modify the surface characteristics of the microsphere. The enolic acid may include one or more enolic acid molecules coupled to different locations on the microsphere. A reagent can be coupled to the microsphere via the enolic acid. In other embodiments, the enolic acid may be replaced with an enolic acid derivative or a mixed functional group. In further embodiments, the enolic acid may be more generally represented as an ionizable polar group that is in conjugation with a chemical group. The chemical group may include, for example, a sulfone group or a carbonyl group.
- In one embodiment, the enolic acid contains at least one hydrophilic group. In another embodiment, the enolic acid may include a deltic, squaric, croconic, or rhodizonic acid, or other homolog. In a different embodiment, the enolic acid may include 5-substituted hydroxy tropolone. In other embodiments, the enolic acid may include a cyanuric acid or a cyanuric acid derivative. In alternative embodiments, the enolic acid may include dimethoxy triazine methylmorpholine modified to contain hydrophilic groups. In a further embodiment, the enolic acid may include a mixed functional group. The mixed functional group may include a boronic acid or a boronic acid derivative. In some embodiments, the enolic acid may include a silicic acid or a silicic acid derivative.
- In an embodiment, coupling the enolic acid to the microsphere may include copolymerizing a monomer containing a vinyl group and the enolic acid with a different monomer to form the microsphere having the modified surface characteristics. In a different embodiment, coupling the enolic acid to the microsphere may include attaching the enolic acid to a surface of the microsphere.
- The modified surface characteristics may increase a stability of the reagent when the reagent is coupled to the microsphere. The modified surface characteristics may also improve performance of an assay carried out with the microsphere. The reagent may include, for example, a biomolecule.
- The surface characteristics may include charge density. In addition, or alternatively, the surface characteristics may include pKa. Each of the embodiments of the method described above may include any other step(s) described herein. In addition, the method may obviously include altering the surface characteristics as described above of multiple microspheres simultaneously (i.e., in the same steps).
- Another embodiment relates to a microsphere that includes an enolic acid coupled to a polymer core of the microsphere such that the enolic acid modifies surface characteristics of the microsphere. The enolic acid may include one or more enolic acid molecules coupled to different locations on the microsphere. A reagent can be coupled to the microsphere via the enolic acid. In other embodiments, the enolic acid may be replaced with an enolic acid derivative or a mixed functional group. In further embodiments, the enolic acid may be more generally represented as an ionizable polar group that is in conjugation with a chemical group. The chemical group may include a sulfone group or a carbonyl group.
- In one embodiment, the enolic acid contains at least one hydrophilic group. In another embodiment, the enolic acid may include a deltic, squaric, croconic, or rhodizonic acid or other homolog. In a different embodiment, the enolic acid may include 5-substituted hydroxy tropolone. In other embodiments, the enolic acid may include a cyanuric acid or a cyanuric acid derivative. In a further embodiment, the enolic acid may include dimethoxy triazine methylmorpholine modified to contain hydrophilic groups. In alternative embodiments, the enolic acid may include a mixed functional group. The mixed functional group may include a boronic acid or a boronic acid derivative. In different embodiments, the enolic acid may include a silicic acid or a silicic acid derivative.
- In one embodiment, the enolic acid may be coupled to the polymer core via copolymerization using a monomer containing a vinyl group and the enolic acid with a different monomer. In a different embodiment, the enolic acid may be coupled to the polymer core via attachment of the enolic acid to a surface of the polymer core.
- The modified surface characteristics may increase a stability of the reagent when the reagent is coupled to the microsphere. The modified surface characteristics may also improve performance of an assay carried out with the microsphere. The reagent may be a biomolecule. The surface characteristics may include charge density. In addition, the surface characteristics may include pKa. Each of the embodiments of the microsphere may be further configured, composed, and/or formed as described herein.
- An additional embodiment relates to a kit. The kit includes microspheres. The kit also includes an activating reagent containing an enolic acid. In addition, the kit includes one or more chemicals, one or more devices, or some combination thereof that can be used to couple the enolic acid to a polymer core of the microsphere such that the enolic acid modifies surface characteristics of the microspheres. One or more reagents can be coupled to the microspheres via the enolic acid.
- The kit and these elements of the kit may be further configured as described herein. For example, in some embodiments, the enolic acid may be replaced with an enolic acid derivative or a mixed functional group. In further embodiments, the enolic acid may be more generally represented as an ionizable polar group that is in conjugation with a chemical group. The chemical group may include, for example, a sulfone group or a carbonyl group.
- Other objects and advantages of the invention will become apparent upon reading the following detailed description and upon reference to the accompanying drawings in which:
-
FIG. 1 is a schematic diagram illustrating one example of a measurement system that may be used to perform experiments using embodiments of microspheres described herein. - While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the present invention as defined by the appended claims.
- The terms “microspheres,” “particles,” and “beads” are used interchangeably herein to refer to discrete solid substances having any suitable size and shape known in the art and having a surface to which one or more surface modifiers described herein may be coupled.
- As used herein, the term “surface modifier” generally refers to one or more molecules that can be coupled to or otherwise located on a surface of a microsphere and that can alter a characteristic of the surface of the microsphere.
- As used herein, the term “reagent” generally refers to a molecule that is coupled to a microsphere such that the reagent can react with an analyte during an assay or other experiment performed using the microsphere. Examples of appropriate reagents include, but are not limited to, biomolecules such as proteins, nucleotides, oligonucleotides, enzymes, antigens, antibodies, or any other molecule involved in or related to biological functioning of a human, animal, plant, etc., drug candidates, and dyes.
- Methods of forming microspheres having surfaces (e.g., polystyrene surfaces) with unusual acidity are generally described herein. For example, methods are described herein for coupling one or more surface modifiers such as enolic acid derivatives to microspheres. In one embodiment, a method for altering surface characteristics of a microsphere includes coupling an enolic acid to the microsphere to modify the surface characteristics of the microsphere. A reagent can be coupled to the microsphere via the enolic acid. Although the method embodiments are described herein with respect to a microsphere, it is to be understood that an enolic acid may be coupled to multiple microsphere simultaneously (i.e., in the same step or steps of the method).
- The surface properties of polymeric microspheres play an important role in many applications involving a wide spectrum of bioassays. For example, the surface characteristics of microspheres determine if and which reagents can be attached to the microspheres. In addition, the surface characteristics of microspheres may determine the amount, predictability, repeatability, uniformity, etc. in which reagents can be coupled to the microspheres. In most commercially available microspheres, functional monomers terminating in COOH or SO3H groups have been used to form the activated (or functionalized) surface of the polymer core of the microspheres. Acidic microsphere surfaces are currently produced using groups such as carboxyl, sulfoxide, hydroxide, boronic acid and silicic acid.
- The methods described herein, however, include modifying microsphere surfaces using surface modifiers such as ionizable polar groups in conjugation with a chemical group such as sulfone or carbonyl groups. For example, microsphere surfaces, as described herein, may be charged (or functionalized) with groups including, but not limited to, carbonyl and OH on adjacent carbon atoms and in conjugation, carbonyl and OH separated by a double bond or by another conjugating link, sulfone and OH in conjugation, carbonyl and COOH, sulfone and COOH, boronic acid and OH, and silicic acid and COOH. In contrast, acids currently used as surface modifiers include ionizable groups located on a carbon, boron, sulfur or silicon atom.
- Enolic acids contain oxo and hydroxyl groups located on different atoms, which are separated by one or more double bonds. Depending on the pH of the solution in which microspheres are disposed, enolic acid groups located on the surface of the microspheres can be ionized and can influence the surface charge (e.g., charge density) of the microsphere and the interfacial charge (i.e. the charge at the interface between the aqueous solution and the microsphere surface). In other words, the enolic acid may be coupled to the microsphere to modify surface characteristics such as surface charge and interfacial charge of the microsphere. These changes in the surface charge and the interfacial charge, in turn, can control chemical binding (or coupling) to the surface of the microspheres and particularly coupling between reagents such as biomolecules and the solid surface. The reagent(s) may also be coupled to the microsphere via the enolic acid.
- The methods described herein can be performed using the following enolic acids, enolic acid derivatives and mixed functional groups. For example, the method described herein can be performed using enolic acids such as squaric, cyanuric, and boronic acids, as well as seven membered hydroxy-tropolone and trialkyl silyl compounds.
- U.S. Patent Application Publication No. 2004/0039201 to Lugade et al., which is incorporated by reference as if fully set forth herein, describes the use of squaric acid fluoride as a preactivated enolic acid fluoride for the covalent coupling of the amino groups of biomolecules. The methods described herein utilize several enolic acids and their derivatives in developing additional reagents for an array of biomedical applications.
- In one embodiment, the methods described herein may be performed using enolic acids such as squaric acid or a derivative thereof. Squaric acid is a substantially strong, dibasic acid having a pKa in the range of about 2 to about 3.5. By transferring two protons, squaric acid can generate a squarate dianion, which is a relatively rigid and delocalized planar aromatic dianion capable of acting as a powerful acceptor of hydrogen bonds. Other homologues of this acid such as deltic, croconic, and rhodizonic acid can be used in the method embodiments described herein. Surfaces with appended squaric acid esters (made from an amine containing surface) have been used to conjugate with amine containing molecules. Examples of methods involving squaric acids are described by Blixt, O. et al., in “Enymatic glycosoylation of reducing oligosaccharides linked to a solid phase or a lipid via a cleavable squarate linker,” Carbohydrate Research, 1999, 319, 80-91, and U.S. Pat. No. 6,602,692 to Glusenkamp et al. and U.S. Pat. No. 6,656,876 to Aberg et al., which are incorporated by reference as if fully set forth herein. In the methods described herein, however, squaric acid is used to modify surface characteristics such as the surface pKa and surface charge of microspheres.
- In another embodiment, the methods described herein may be performed using oxocarbon acids. Oxocarbons of the general formula shown below, where R=Cl, alkyl, and aryl, were first reported by Cole, R. J. et al. Science, 1973, 179, 1324 and Schmidt, A. H., Synthesis, 1978, 1, which are incorporated by reference as if fully set forth herein.
Using an appropriate linker group, R, the surface characteristics of microspheres can be modified with enolic acids that contain the general structure shown in Table 1, entry 1. - Vinyl containing monomers such as 3-hydroxy-4-(4-styryl)-3-cyclobutene-1,2-dione can be prepared by an extension of a general method reported in the literature by Meier, H. et al., Tetrahedron Lett. 1996, 37(8), 1191, which is incorporated by reference as if fully set forth herein. This functional monomer can be used to couple enolic acid groups to the surface of microspheres during polymerization. Vinyl enolic acids such as 3-hydroxy-4-vinyl-3-cyclobutene-1,2-dione have been reported by Sprenger, H. E. et al., Angew. Chem. Int. Ed. Engl., 1968, 7, 530, which is incorporated by reference as if fully set forth herein.
-
- A modification of a method described by Uemura, T. et al., Mol. Cryst. Liq. Cryst. 1983, 95, 287, which is incorporated by reference as if fully set forth herein, can be used to produce 5-aminotropolone which can be attached to the surface of microspheres as shown below.
Procedures for the synthesis of various substituted tropolones have been reported for example, in J. Chem. Soc. (C) 1971, 878; J. Chem. Soc. (PI) 1976, 2329; J. Chem. Soc. 1951, 2352, which are incorporated by reference as if fully set forth herein. Synthesis of tropolones and microspheres with tropolone surface groups is described in Examples 4-6 provided below. - In further embodiments, other enolic acids that may be used in the methods described herein include cyanuric acid and its derivatives, boronic acid and its derivatives, silicic acids and their derivatives, and other enolic acids and their derivatives.
- Cyanuric acid and derivatives thereof include compounds that can be represented by the general formula shown in Table 1, Entry 2. Resins activated with cyanuric chloride and resin bound triazine used to activate carboxyl groups for nucleophilic substitution at the carboxyl groups to produce amides are described by Venkataraman, K. et al., Tetrahedron Lett., 1979, 32, 3037, which is incorporated by reference as if fully set forth herein
- Vinyl monomers of triazine such as that shown below may be used to couple cyanuric acid or its derivatives onto the surface of microspheres via incorporation during polymerization.
For example, vinyl monomers like the one shown above can be utilized for the preparation of microspheres with surface enolic acids including cyanuric acid and its derivatives. Similarly barbituric acid and its various derivatives can be incorporated either through polymerization or through a suitably functionalized linker (see, for example, Table 1, entry 3). - Other enolic acids and their derivatives that can be used in the method embodiments described herein include heterocyclic compounds represented by the general structures shown in Table 1, entries 5 and 6, which exhibit weak to moderate acidity and are available from various commercial sources. Enolic acids belonging to the family of ascorbic acids (see below) have a pKa of around 4.0-4.2.
- “Quinonoid” compounds (see Table 1, entry 7) such as chloranilic acid are also commercially available. With a suitable linker, these compounds can be immobilized on a microsphere surface. 2-Hydroxynaphthoquinone is a moderately strong acid and resembles oxocarbon acids. This compound has been described as a vinylog of semi-squaric acid. The hydroxy groups of 2-hydroxynaphthoquinone may be replaced by boronic acid, silic acid, selenic acid or phosphoric acid groups to alter the acidity of this compound and therefore the microsphere surface to which it is coupled.
- Hydrazide derivatives such as Luminol (Table 1, entry 8) exhibit ionizable OH groups and can be immobilized on a microsphere surface using an amino group. Compounds like Luminol have been used for chemiluminescence analysis.
- 1,3-Cyclohexandione and its derivatives (Table 1, entry 9) possess pKa values around 4.8. Compounds like phenolenone are commercially available and with a suitable linker can be coupled to microspheres. The acidity of such compounds can be adjusted by introducing electron withdrawing and electron releasing groups including any such appropriate groups known in the art to such compounds.
- The oxicam derivative “Mobic” is a member of the enolic acid group of nonsteroidal anti-inflammatory drugs. It has pKa values of 1.1 and 4.2. The high acidity of this compound is imparted by the presence of sulfone moieties in its structure. The incorporation of sulfones in conjugation with OH groups can be used to enhance the acidity of enolic acids (see Table 1, entries 10-13).
- The structure shown in Table 1,
entry 14 represents a class of acids that belongs to a general group classified as ‘oxo’ acids, which mimic the acidity of oxo carbon acids. - Examples of the most preferred vinyl monomers that can be polymerized with other monomers to yield microspheres having enolic acid containing surfaces are shown in Table 1, entry 15.
- In additional embodiments, the methods described herein may be performed using “mixed enolic acids.” For example, the availability of aniline and anisole squarates facilitates the immobilization of mixed enolic acids represented by the general structures shown in Table 1, entries 16-19. The syntheses of similar compounds are described by Gauger, J. et al., Chem. Ber., 1970, 103, 2696, Bellus, D., J. Am. Chem. Soc., 1978, 100, 8026, Law, K. Y. and Bailey, P. C., J. Org. Chem., 1992, 57, 3278, and Meier, H. et al., Tetrahedron Lett., 1996, 37, 1191, which are incorporated by reference as if fully set forth herein. Amino derivativized tropolone can be attached to oxocarbon acids such as squaric acid (Table 1, entry 19).
- In addition, the methods described herein may be performed using “activated enolic acids.” For example, any of the microspheres “coated with” enolic acids (i.e., having enolic acid molecules located on the microsphere surface) described herein can be activated to its enolic acid fluoride form using the procedure for converting squaric acid to squaric acid fluoride that is described in U.S. Patent Application Publication No. 2004/0039201 to Lugade et al. These new enolic acid fluorides could be used as crosslinkers in a manner similar to that in which the squaric acid fluoride groups are used as crosslinkers as described by Lugade et al. in this patent application.
- By virtue of their bi-fuctional nature, enolic acid attached microspheres can also be used to form specific metal ion complexes (e.g. see below). Metal chelator complexes, in turn, can be used for site-specific capture of biomolecules and for affinity purification of proteins or peptides.
Table 1: Examples of Enolic Acids - The letter ‘A’ in the table represents any appropriate linker group known in the art that can be used to couple the enolic acid containing moiety to a microsphere (e.g., to a functional group located on the surface of the microsphere). The group ‘A’ may also contain a vinyl group to allow the enolic acid to be incorporated into a microsphere during polymerization of the polymer core of the microsphere.
Oxocarbon acids and Derivatives 1. Cyanuric acid and derivatives 2. Barbituric acid and Derivatives 3. Tropolones, Benzotropolones and Derivatives 4. Heterocyclic 5. Five membered rings/Ascorbic acid Type 6. Quinonoid Type 7. Luminol and Indophenol Type 8. 3-Hydroxy-enones or 1,3 diones 9. Sulfones 10. 11. 12. 13. Oxalic acid type 14. Vinyl Monomers 15. Mixed 16. 17. 18. 19. - An example of a cyanuric acid derivative that can be used as a surface modifier and coupling activator for microspheres in the method embodiments described herein is given below.
- The compound dimethoxy triazine methylmorpholine (DMTMM) was investigated as a surface modifier for microspheres. In the literature, DMTMM has been used as a peptide bond activation reagent. Alkyl substituted triazine derivatives are commercially available as DMTMM. DMTMM can also be synthesized as described in Examples 1 and 2 provided below. We explored its use as a surface modifier to which a reagent can be coupled for microspheres (see below).
- The coupling of DMTMM to microspheres performed well, but the microspheres coupled to DMTMM are more hydrophobic than microspheres activated with the commonly used surface modifier, sulfo-N-hydroxysuccinimide (sulfo-NHS). In other words, the DMTMM modified microspheres exhibited a propensity to stick to each other rather than dispersing in an aqueous solution. In contrast, microspheres with sulfo-NHS groups attached thereto retain a water-loving (i.e., hydrophilic) group (the sulfo) on the surface thereof when the sulfo-NHS is reacted with the original carboxyl group on the microspheres. The microspheres, therefore, stay well dispersed in water and aqueous solutions and solvents. In contrast, DMTMM is soluble in water because of the quaternary ammonium salt moiety that it contains. After reaction with a carboxyl group on the surface of a microsphere, this positive charge is lost along with the water solubility. In this manner, hydrophilic carboxyl groups on the surface of the microsphere are replaced with hydrophobic aromatic rings thereby reducing the hydrophilicity of the microspheres.
- To increase the hydrophilicity of the activated microspheres, the methoxy groups of DMTMM were replaced with more hydrophilic chains as shown in the reaction below. Di-(polyethylene glycol) triazine chlorides have been prepared previously to introduce polyethylene glycol chains into biomolecules, as described in Japanese Patent No. 8092294 to Sakurai, et al. and reviewed by Roberts et al., Adv. Drug Delivery Rev., 2002, 54, 459-476, which are incorporated by reference as if fully set forth herein. Other triazine compounds containing hydrophilic groups have been described by Pyzhov et al., Deposited Doc, 1982, VINITI 1408-82; Martin et al., J. Prak. Chem. 1981, 323, 694-699; Kashkin, et al.; Zhurnal Organichkoi Khimii, 1976, 12, 2030-2033; and Ahne et al., Synthesis, 1975, 184-186, which are incorporated by reference as if fully set forth herein. In one embodiment, therefore, the enolic acid used in the methods described herein includes DMTMM modified to contain hydrophilic groups. Hydrophilic groups such as quat-ammonium, sulfonate, phosphonate, polyethylene glycol (PEG) chains, dendrimeric structures, etc. could be used to increase the hydrophilicity of DMTMM and other surface modifiers subsequent to coupling of the surface modifiers to functional groups on the surface of the microsphere. The hydrophilic derivatives of DMTMM are used in the methods described herein as a replacement for EDC/NHS surface modifying and activating agents.
X20= -
- —(CH2CH2—O)nCH3 n=1-100
- —(CH2)n—SO3 −
- —(CH2)n—PO3 −
- —(CH2)n—N(Y20)3 +, (Y20=H, Alkyl), n=1-3
- —Si(OCH3)2—(CH2)3—N(CH3)3 +
- —O-Dextran
- —O-carbohydrate
- —O-cellulose
- —O-phosphatidyl choline
One example of altering surface characteristics of (activating) microspheres with such a hydrophilic derivative is provided in Example 3 below.
- Enolic acid containing surfaces of microspheres can be generated by two approaches. For example, a monomer may be obtained that contains both a vinyl group and an enolic acid group, and the monomer may be copolymerized with other monomers such as styrene to produce microspheres having enolic acid groups on the surface of the microspheres and thereby having the modified surface characteristics. The polymerization may be performed using any suitable method known in the art. Alternatively, coupling the enolic acid to the microsphere may include attaching the enolic acid to a surface of the microsphere. In other words, the surface of an already formed microsphere may be altered by attachment of the enolic acid. Attachment of an enolic acid to a formed microsphere may be performed as described herein or using any other suitable method known in the art.
- In one embodiment, the enolic acid may include one or more enolic acid molecules coupled to different locations on the microsphere. In other words, two or more different enolic acids may be coupled to a microsphere. Molecules of each of the different enolic acids may be coupled directly to functional groups present on the microsphere surface. Alternatively, monomers containing different enolic acids may be copolymerized possibly in combination with other monomers to form the polymer core of the microsphere having the enolic acids located on a surface thereof.
- In one embodiment, the modified surface characteristics increase a stability of the reagent when the reagent is coupled to the microsphere. In another embodiment, the modified surface characteristics improve performance of an assay carried out with the microsphere. For example, different biomolecules may require different surface environments (i.e., the environment proximate to the surface of the microsphere) for optimal assay performance (e.g., for optimal binding to or reaction with an analyte in a sample). These local environments can be created and adjusted using the proposed surface groups. Some of the surface modifiers described herein will increase reagent stability or improve assay performance. Other surface modifiers described herein allow for easier attachment of the biomolecules to the microsphere surface.
- For example, the DMTMM based surface modifier described above may be used to reduce inconsistent coupling of biological material to the surface of microspheres. In this manner, the surface modifier may not necessarily be used to form a “self-coupling” microsphere (i.e., a microsphere having surface groups that selectively and spontaneously couple to a reagent), but the surface modifier may be used to replace the EDC/sulfo-NHS cross-linking pair currently used to provide a microsphere having an improved surface modifier attached thereto and improved surface characteristics.
- In addition, in some instances, standard EDC/sulfo-NHS coupling procedures may be somewhat problematic. For example, EDC and sulfo-NHS are hygroscopic solids that react with moisture in the air, and special precautions must be used to keep the surface modifier in the bottle fresh. Working solutions of the surface modifiers must be made immediately before use. The urea side products from EDC activation are sometimes hard to remove from the bead suspension and can interfere with subsequent coupling reactions or assays.
- The methods described herein provide a number of advantages over standard methods for coupling reagents to microspheres. For example, DMTMM type cross-linkers can be used alone to activate microspheres (instead of using two surface modifiers). In addition, aqueous solutions of DMTMM are stable for several hours at room temperature and much longer if kept frozen. Furthermore, DMTMM crystals are more stable to moisture in the air and so are easier to work with successfully. Moreover, the synthesis of DMTMM is less complicated than that for EDC, which may increase the quality and consistency of the surface modifier.
- Another embodiment relates to a microsphere that includes an enolic acid coupled to a polymer core of the microsphere such that the enolic acid modifies surface characteristics of the microsphere. The polymer core of the microsphere may be formed of any suitable polymer known in the art. The enolic acid may include one or more enolic acid molecules coupled to different locations on the microsphere. A reagent can be coupled to the microsphere via the enolic acid. In other embodiments, the enolic acid may be replaced with an enolic acid derivative or a mixed functional group. In further embodiments, the enolic acid may be more generally represented as an ionizable polar group that is in conjugation with a chemical group. The chemical group may include a sulfone group or a carbonyl group.
- In one embodiment, the enolic acid contains at least one hydrophilic group. In another embodiment, the enolic acid may include a deltic, squaric, croconic, or rhodizonic acid or other homolog. In a different embodiment, the enolic acid may include 5-substituted hydroxy tropolone. In other embodiments, the enolic acid may include a cyanuric acid or a cyanuric acid derivative. In a further embodiment, the enolic acid may include DMTMM modified to contain hydrophilic groups. In alternative embodiments, the enolic acid may include a mixed functional group. The mixed functional group may include a boronic acid or a boronic acid derivative. In different embodiments, the enolic acid may include a silicic acid or a silicic acid derivative.
- In one embodiment, the enolic acid may be coupled to the polymer core via copolymerization using a monomer containing a vinyl group and the enolic acid with a different monomer. In a different embodiment, the enolic acid may be coupled to the polymer core via attachment of the enolic acid to a surface of the polymer core.
- The modified surface characteristics may increase a stability of the reagent when the reagent is coupled to the microsphere. The modified surface characteristics may also improve performance of an assay carried out with the microsphere. The reagent may be a biomolecule. The surface characteristics may include charge density. In addition, the surface characteristics may include pKa. Each of the embodiments of the microsphere may be further configured, composed, and/or formed as described herein. Each of the embodiments of the microsphere described above has all of the advantages of the methods described above.
- Microspheres having a surface modifier described herein attached thereto can be supplied as “ready to use” microspheres. In addition, one or more surface modifiers can be supplied as a separate kit to activate surface groups on (couple to surface groups on) the microspheres.
- In one embodiment, the kit includes microspheres. The kit also includes an activating reagent containing one or more surface modifiers such as an enolic acid. In addition, the kit includes one or more chemicals, one or more devices, or some combination thereof that can be used to couple the enolic acid to a polymer core of the microsphere (or groups on the surface of the polymer core of the microsphere) such that the enolic acid modifies surface characteristics of the microspheres. One or more reagents can be coupled to the microspheres via the enolic acid. The reagent(s) may or may not be included in the kit.
- The kit and these elements of the kit may be further configured as described herein. For example, in some embodiments, the enolic acid may be replaced with an enolic acid derivative or a mixed functional group. In further embodiments, the enolic acid may be more generally represented as an ionizable polar group that is in conjugation with a chemical group. The chemical group may include, for example, a sulfone group or a carbonyl group. Each of the embodiments of the kit described herein has all of the advantages of the methods described above.
- The following examples are not to be considered limiting embodiments of the invention and are included herein for example purposes only.
- The procedures in Examples 1 and 2 are based on the synthesis of DMTMM described by Kunishima, M. et al., Tetrahedron Lett., 40, 5327-5330, 1999, and Cronin, J. S. et al., Syn. Commun., 26 (18), 3491-3494, 1996, which are incorporated by reference as if fully set forth herein.
- To 14.43 g (190 mmole) of 2-methoxy ethanol, 6.83 g (81 mmole) of sodium bicarbonate, and 1.3 mL (70 mmole) of deionized water at room temperature was added 5.0 g (27 mmole) of cyanuric chloride. The temperature of the solution was raised to 30° C. and stirred for 1 hour at which time the evolution of carbon dioxide ceased. The temperature of the solution was raised to 45° C. and stirring was continued overnight. After cooling, the mixture was filtered, and the solids rinsed with methylene chloride. The combined filtrates were concentrated in vacuo to 8 g of 2-chloro-4,6-di-(2-methoxyethoxy)-1,3,5-triazine as a milky liquid which solidified to a waxy solid in the freezer (−18° C).
- Proton nuclear magnetic resonance (1H NMR) of the product produced the following results: (CDCl3, 60 MHz) δ 4.7-4.4 (m, 4 Hz), 3.8-3.5 (m, 4 Hz), 3.4 (s, 6 Hz). Infrared (IR) spectroscopy of the product (neat) found the following characteristic IR absorption frequencies: 1557 cm−1, 1417 cm−1, 1330 cm−1, 1115 cm−1, 1050 cm−1, 1022 cm−1, and 814 cm−1.
- To 27.6 g (190 mmole) of 2-(diisopropylamino)ethanol, 6.83 g (81 mmole) of sodium bicarbonate, and 1.3 mL (70 mmole) of deionized water at room temperature was added 5.0 g (27 mmole) of cyanuric chloride. The temperature of the solution was raised to 30° C. and stirred for 1 hour at which time the evolution of carbon dioxide ceased. The temperature of the solution was raised to 45° C. and stirring was continued overnight. After cooling, the mixture was filtered, and the solids rinsed with methylene chloride. The combined filtrates were concentrated in vacuo to 6 g of 2-chloro-4,6-di-(2-(diisopropylamino)ethoxy)-1,3,5-triazine as a liquid.
- To 1.05 g (4 mmole) of 2-chloro-4,6-di-(2-methoxyethoxy)-1,3,5-triazine (obtained as described in Example 1) in 3.5 mL of dry tetrahydrofuran was added 530 μL of N-methyl morpholine. The solution was stirred for 30 minutes, filtered, and dried in an Abderhalden apparatus using acetone for 12 hours to yield 0.5 g (34%) of 4-(4,6-di-(2-methoxyethoxy)-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride as a white powder. IR spectroscopy of the product (neat) identified the following characteristic IR absorption frequencies: 1605 cm−1, 1417 cm−1, 1336 cm−1, 1300 cm−1, 1118 cm−1, 1094 cm−1, 1068 cm−1, 1053 cm−1, 1028 cm−1, 1009 cm'1, 991 cm−1, 972 cm−1, 858 cm−1, and 821 cm−1.
- 4-(4,6-di-(2-diisopropylamino)ethoxy)-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride was produced in a similar manner from the chloride obtained in Example 2.
- To an aliquot of 5.0E6 carboxylated microspheres suspended in 90 μL of an appropriate, non-nucleophilic buffer (pH 5-9) was added 10 μL of a 50 mg/mL solution of one of the newly described hydrophilic DMTMM derivatives (e.g., one of the compounds as described in Example 3) in the same buffer. The suspension was agitated for 20-60 minutes. The excess reagent could be separated from the microspheres by any convenient method known to the art (e.g. repeated centrifugation and decantation). The activated microspheres will now react spontaneously with amine containing molecules (e.g. protein) in about 2 hours in an appropriate, non-nucleophilic buffer (pH 4-9).
- To a stirred solution of 2.05 g (16.9 mmole) of tropolone in 6 mL of deionized water and 6 mL of glacial acetic acid was added dropwise a solution of 1.25 g (18.1 mmole) of sodium nitrite in 5 mL of deionized water. After an additional 1 hour of stirring, the resulting solids were filtered and dried in vacuo for 2 hours to give 5-nitroso-tropolone as a yellow solid. IR spectroscopy of the product (neat) found the following characteristic IR absorption frequencies: 1603 cm−1, 1519 cm−1, 1316 cm−1, 1110 cm−1, 1015 cm−1, 845 cm−1, 812 cm−1, and 781 cm−1.
- To a stirred solution of 0.39 g of 5-nitrosotropolone (2.6 mmole, obtained from the previous example) and 10 mL of absolute ethanol was added 2.92 g of Tin (II) chloride (12.9 mmole). After 40 minutes at reflux the solution was cooled, filtered, and the liquefied portion was partitioned between ethyl acetate and water. The organic fraction was concentrated in vacuo to give 35 mg (10%) of 5-aminotropolone as a yellow solid. IR spectroscopy of the product (neat) found the following characteristic IR absorption frequencies: 3319 cm−1, 3181 cm−1, 2925 cm−1, 1511 cm−1, 1410 cm−1, 1261 cm−1, 837 cm−1, 781 cm−1, and 739 cm−1.
- To 100E6 carboxylated microspheres (previously activated with sulfo-N-hydroxysuccinimide and EDC) in 0.5 mL of carbonate buffer (pH 9) was added 2 mg of 5-aminotropolone dissolved in 25 μL of dimethyl sulfoxide. The suspension was agitated for 4 hours, and the excess reagent was washed away from the microspheres.
- Turning now to the drawings,
FIG. 1 illustrates one example of a measurement system that may be used to perform experiments with embodiments of the microspheres described herein. It is noted thatFIG. 1 is not drawn to scale. In particular, the scale of some of the elements of the figure is greatly exaggerated to emphasize characteristics of the elements. Some elements of the measurement system such as a digital signal processor (DSP) have not been included in the figure for the sake of clarity. - In
FIG. 1 , the measurement system is shown along a plane through the cross-section ofcuvette 12 through which microspheres 10 flow. In one example, the cuvette may be a standard quartz cuvette such as that used in standard flow cytometers. Any other suitable type of viewing or delivery chamber, however, may also be used to deliver the sample for analysis.Microspheres 10 may be formed according to the embodiments described herein. - The measurement system includes
light source 14.Light source 14 may include any appropriate light source known in the art such as a laser. The light source may be configured to emit light having one or more wavelengths such as blue light or green light.Light source 14 may be configured to illuminate the microspheres as they flow through the cuvette. The illumination may cause the microspheres to emit fluorescent light having one or more wavelengths or wavelength bands. In some embodiments, the system may include one or more lenses (not shown) configured to focus light from the light source onto the microspheres or the flowpath. The system may also include more than one light source. In one embodiment, the light sources may be configured to illuminate the microspheres with light having different wavelengths (e.g., blue light and green light). In some embodiments, the light sources may be configured to illuminate the microspheres at different directions. - Light scattered forwardly from the microspheres may be directed to
detection system 16 by foldingmirror 18 or another such light directing component. Alternatively,detection system 16 may be placed directly in the path of the forwardly scattered light. In this manner, the folding mirror or other light directing components may not be included in the system. In one embodiment, the forwardly scattered light may be light scattered by the microspheres at an angle of about 180 degrees from the direction of illumination bylight source 14, as shown inFIG. 1 . The angle of the forwardly scattered light may not be exactly 180 degrees from the direction of illumination by the light source such that incident light from the light source may not impinge upon the photosensitive surface of the detection system. For example, the forwardly scattered light may be light scattered by the microspheres at angles less than or greater than 180 degrees from the direction of illumination (e.g., light scattered at an angle of about 170 degrees, about 175 degrees, about 185 degrees, or about 190 degrees). - Light scattered and/or emitted by the microspheres at an angle of about 90 degrees from the direction of illumination by the light source may also be collected. In one embodiment, this scattered light may be separated into more than one beam of light by one or more beamsplitters or dichroic mirrors. For example, light scattered at an angle of about 90 degrees to the direction of illumination may be separated into two different beams of light by
beamsplitter 20. The two different beams of light may be separated again by 22 and 24 to produce four different beams of light. Each of the beams of light may be directed to a different detection system, which may include one or more detectors. For example, one of the four beams of light may be directed tobeamsplitters detection system 26.Detection system 26 may be configured to detect light scattered by the microspheres. - The other three beams of light may be directed to
28, 30, and 32.detection systems 28, 30, and 32 may be configured to detect fluorescence emitted by the microspheres. Each of the detection systems may be configured to detect fluorescence of a different wavelength or a different range of wavelengths. For example, one of the detection systems may be configured to detect green fluorescence. Another of the detection systems may be configured to detect yellow-orange fluorescence, and the other detection system may be configured to detect red fluorescence.Detection systems - In some embodiments,
34, 36, and 38 may be coupled tospectral filters 28, 30, and 32, respectively. The spectral filters may be configured to block fluorescence of wavelengths other than that which the detection systems are configured to detect. In addition, one or more lenses (not shown) may be optically coupled to each of the detection systems. The lenses may be configured to focus the scattered light or emitted fluorescence onto a photosensitive surface of the detectors.detection systems - The detector's output current is proportional to the fluorescent light impinging on it and results in a current pulse. The current pulse may be converted to a voltage pulse, low pass filtered, and then digitized by an A/D converter. A DSP integrates the area under the pulse to provide a number which represents the magnitude of the fluorescence.
- In some embodiments, the output signals generated from fluorescence emitted by the microspheres may be processed to determine an identity of the microspheres and information about a reaction taken or taking place on the surface of the microspheres. For example, two of the output signals may be used to determine an identity of the microspheres, and the other output signals may be used to determine a reaction taken or taking place on the surface of the microspheres. The identity of the microspheres may be determined based on a ratio of the output signals generated in two or more different detection windows. For example, if
30 and 32 have different detection windows, the identity of the microspheres may be determined from a ratio of output signals generated bydetection systems detection system 30 to output signals generated bydetection system 32, coupled with the intensity of each signal. Therefore, the selection of the detectors and the spectral filters may vary depending on the type of dyes incorporated into or bound to the microspheres and/or the reaction being measured (i.e., the dye(s) incorporated into or bound to the reactants involved in the reaction). - Although the system of
FIG. 1 is shown to include two detection systems having two different detection windows for distinguishing between microspheres having different dye characteristics, it is to be understood that the system may include more than two such detection windows (i.e., 3 detection windows, 4 detection windows, etc.). In such embodiments, the system may include additional beamsplitters and additional detection systems having other detection windows. The detection windows for more than two detection systems may be determined as described above. In addition, spectral filters and/or lenses may be coupled to each of the additional detection systems. - In another embodiment, the system may include two or more detection systems configured to distinguish between different materials that are reacted on the surface of the microspheres. The different reactant materials may have dye characteristics that are different than the dye characteristics of the microspheres.
- Additional examples of measurement systems that may be used to perform measurements on the surface modified microspheres described herein are illustrated in U.S. Pat. No. 5,981,180 to Chandler et al., U.S. Pat. No. 6,046,807 to Chandler, U.S. Pat. No. 6,139,800 to Chandler, U.S. Pat. No. 6,366,354 B1 to Chandler, U.S. Pat. No. 6,411,904 B1 to Chandler, U.S. Pat. No. 6,449,562 B1 to Chandler et al., and U.S. Pat. No. 6,524,793 B1 to Chandler et al., which are incorporated by reference as if fully set forth herein. The measurement system described herein may also be further configured as described in these patents. In addition, the assays and experiments in which the microsphere embodiments described herein may be used include any of the assays and experiments described in these patents and any other assays and experiments known in the art.
- It will be appreciated to those skilled in the art having the benefit of this disclosure that this invention is believed to provide methods for altering surface characteristics of a microsphere. Further modifications and alternative embodiments of various aspects of the invention will be apparent to those skilled in the art in view of this description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as the presently preferred embodiments. Elements and materials may be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein without departing from the spirit and scope of the invention as described in the following claims.
Claims (42)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/247,943 US7867774B2 (en) | 2004-10-12 | 2005-10-11 | Methods for altering surface characteristics of microspheres |
| US12/969,863 US8153440B2 (en) | 2004-10-12 | 2010-12-16 | Methods for altering surface characteristics of microspheres |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61833804P | 2004-10-12 | 2004-10-12 | |
| US11/247,943 US7867774B2 (en) | 2004-10-12 | 2005-10-11 | Methods for altering surface characteristics of microspheres |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/969,863 Division US8153440B2 (en) | 2004-10-12 | 2010-12-16 | Methods for altering surface characteristics of microspheres |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20060078997A1 true US20060078997A1 (en) | 2006-04-13 |
| US7867774B2 US7867774B2 (en) | 2011-01-11 |
Family
ID=35709114
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/247,943 Active 2028-12-11 US7867774B2 (en) | 2004-10-12 | 2005-10-11 | Methods for altering surface characteristics of microspheres |
| US12/969,863 Expired - Fee Related US8153440B2 (en) | 2004-10-12 | 2010-12-16 | Methods for altering surface characteristics of microspheres |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/969,863 Expired - Fee Related US8153440B2 (en) | 2004-10-12 | 2010-12-16 | Methods for altering surface characteristics of microspheres |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7867774B2 (en) |
| EP (1) | EP1802973B1 (en) |
| JP (1) | JP4988578B2 (en) |
| KR (1) | KR101230020B1 (en) |
| CN (1) | CN101044403B (en) |
| AT (1) | ATE467127T1 (en) |
| CA (1) | CA2583474C (en) |
| DE (1) | DE602005021135D1 (en) |
| WO (1) | WO2006044275A2 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100040556A1 (en) * | 2008-08-13 | 2010-02-18 | Davis Mark E | Carrier nanoparticles and related compositions, methods and systems |
| US20160146802A1 (en) * | 2014-11-20 | 2016-05-26 | General Electric Company | Porous membranes with a polymer grafting, methods and uses thereof |
| US10166291B2 (en) | 2013-03-01 | 2019-01-01 | California Institute Of Technology | Targeted nanoparticles |
| CN109946453A (en) * | 2019-04-02 | 2019-06-28 | 珠海丽珠试剂股份有限公司 | A kind of coupling method of proliferating cell nuclear antigen |
| US10717825B2 (en) | 2015-07-01 | 2020-07-21 | California Instite of Technology | Cationic mucic acid polymer-based delivery system |
| US11738092B2 (en) | 2019-12-04 | 2023-08-29 | Dantari, Inc. | Methods and compositions for synthesis of therapeutic nanoparticles |
| US11998616B2 (en) | 2018-06-13 | 2024-06-04 | California Institute Of Technology | Nanoparticles for crossing the blood brain barrier and methods of treatment using the same |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105007905A (en) * | 2013-03-01 | 2015-10-28 | 加州理工学院 | Targeted nanoparticles |
| US9132097B2 (en) | 2013-03-01 | 2015-09-15 | California Institute Of Technology | Nanoparticles stabilized with nitrophenylboronic acid compositions |
| WO2015178946A1 (en) | 2014-04-04 | 2015-11-26 | Biodesix, Inc. | Treatment selection for lung cancer patients using mass spectrum of blood-based sample |
| JP2019108371A (en) * | 2019-03-04 | 2019-07-04 | カリフォルニア インスティテュート オブ テクノロジー | Targeted nanoparticles |
Citations (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2657205A (en) * | 1950-01-09 | 1953-10-27 | Hoechst Ag | Dyes containing a vinyl sulfone |
| US4935147A (en) * | 1985-12-20 | 1990-06-19 | Syntex (U.S.A.) Inc. | Particle separation method |
| US5414135A (en) * | 1991-12-30 | 1995-05-09 | Sterling Winthrop Inc. | Vinyl sulfone coupling of polyoxyalkylenes to proteins |
| US5674699A (en) * | 1993-06-08 | 1997-10-07 | Chronomed, Inc. | Two-phase optical assay |
| US5736330A (en) * | 1995-10-11 | 1998-04-07 | Luminex Corporation | Method and compositions for flow cytometric determination of DNA sequences |
| US5763203A (en) * | 1993-03-11 | 1998-06-09 | Sinvent As | Immobilization and separation of cells and other particles |
| US5981180A (en) * | 1995-10-11 | 1999-11-09 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
| US6008406A (en) * | 1994-01-28 | 1999-12-28 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
| US6046807A (en) * | 1998-05-14 | 2000-04-04 | Luminex Corporation | Diode laser based measurement apparatus |
| US6075126A (en) * | 1996-08-05 | 2000-06-13 | Prolinx, Inc. | Phenyldiboronic acid reagents and complexes |
| US6139800A (en) * | 1997-06-23 | 2000-10-31 | Luminex Corporation | Interlaced lasers for multiple fluorescence measurement |
| US6146833A (en) * | 1997-02-11 | 2000-11-14 | Beckman Coulter, Inc. | Polymeric reagents for immobilizing biopolymers |
| US6268222B1 (en) * | 1998-01-22 | 2001-07-31 | Luminex Corporation | Microparticles attached to nanoparticles labeled with flourescent dye |
| US6411904B1 (en) * | 1998-05-14 | 2002-06-25 | Luminex Corporation | Zero dead time architecture for flow cytometer |
| US6449562B1 (en) * | 1996-10-10 | 2002-09-10 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
| US6514295B1 (en) * | 1997-10-14 | 2003-02-04 | Luminex Corporation | Precision fluorescently dyed particles and methods of making and using same |
| US6524793B1 (en) * | 1995-10-11 | 2003-02-25 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
| US6602692B1 (en) * | 1993-12-06 | 2003-08-05 | Gluesenkamp Karl-Heinz | Method for immobilizing biomolecules and affinity ligands on polymer carriers |
| US6630577B2 (en) * | 1996-08-05 | 2003-10-07 | Prolinx, Inc. | 1,2-Phenylenediboronic acid reagents and complexes |
| US6656876B1 (en) * | 1998-10-16 | 2003-12-02 | Amersham Biosciences Ab | Squaric acid activated carrier usable for immobilization of compounds containing amine groups |
| US20040039201A1 (en) * | 2001-11-14 | 2004-02-26 | Lugade Ananda G. | Functionalized compositions for improved immobilization |
| US20040087032A1 (en) * | 1999-08-17 | 2004-05-06 | Chandler Mark B. | Microparticles with multiple fluorescent signals and methods of using same |
| US20050118199A1 (en) * | 2003-10-07 | 2005-06-02 | Esser Mark T. | Process for covalently conjugating polysaccharides to microspheres or biomolecules |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE960534C (en) | 1950-01-09 | 1957-03-21 | Hoechst Ag | Process for the production of real colors and prints |
| EP0230768B1 (en) * | 1985-12-20 | 1992-03-18 | Syntex (U.S.A.) Inc. | Particle separation method |
| JPH0892294A (en) | 1994-09-29 | 1996-04-09 | Teijin Ltd | Human activated protein c derivative |
| ATE439351T1 (en) | 1998-06-24 | 2009-08-15 | Aventis Pharma Inc | FLUOROPHENYL RESIN COMPOUNDS |
| WO2002040698A2 (en) | 2000-11-17 | 2002-05-23 | Surromed, Inc. | Analysis of soluble factor biological markers |
-
2005
- 2005-10-11 WO PCT/US2005/036264 patent/WO2006044275A2/en not_active Ceased
- 2005-10-11 CN CN2005800344200A patent/CN101044403B/en not_active Expired - Fee Related
- 2005-10-11 JP JP2007535861A patent/JP4988578B2/en not_active Expired - Fee Related
- 2005-10-11 EP EP05803799A patent/EP1802973B1/en not_active Ceased
- 2005-10-11 AT AT05803799T patent/ATE467127T1/en not_active IP Right Cessation
- 2005-10-11 CA CA2583474A patent/CA2583474C/en not_active Expired - Lifetime
- 2005-10-11 DE DE602005021135T patent/DE602005021135D1/en not_active Expired - Lifetime
- 2005-10-11 KR KR1020077010845A patent/KR101230020B1/en not_active Expired - Fee Related
- 2005-10-11 US US11/247,943 patent/US7867774B2/en active Active
-
2010
- 2010-12-16 US US12/969,863 patent/US8153440B2/en not_active Expired - Fee Related
Patent Citations (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2657205A (en) * | 1950-01-09 | 1953-10-27 | Hoechst Ag | Dyes containing a vinyl sulfone |
| US4935147A (en) * | 1985-12-20 | 1990-06-19 | Syntex (U.S.A.) Inc. | Particle separation method |
| US5414135A (en) * | 1991-12-30 | 1995-05-09 | Sterling Winthrop Inc. | Vinyl sulfone coupling of polyoxyalkylenes to proteins |
| US5763203A (en) * | 1993-03-11 | 1998-06-09 | Sinvent As | Immobilization and separation of cells and other particles |
| US5674699A (en) * | 1993-06-08 | 1997-10-07 | Chronomed, Inc. | Two-phase optical assay |
| US6602692B1 (en) * | 1993-12-06 | 2003-08-05 | Gluesenkamp Karl-Heinz | Method for immobilizing biomolecules and affinity ligands on polymer carriers |
| US6008406A (en) * | 1994-01-28 | 1999-12-28 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
| US6524793B1 (en) * | 1995-10-11 | 2003-02-25 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
| US5981180A (en) * | 1995-10-11 | 1999-11-09 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
| US6057107A (en) * | 1995-10-11 | 2000-05-02 | Luminex Corporation | Methods and compositions for flow cytometric determination of DNA sequences |
| US5736330A (en) * | 1995-10-11 | 1998-04-07 | Luminex Corporation | Method and compositions for flow cytometric determination of DNA sequences |
| US6630577B2 (en) * | 1996-08-05 | 2003-10-07 | Prolinx, Inc. | 1,2-Phenylenediboronic acid reagents and complexes |
| US6462179B1 (en) * | 1996-08-05 | 2002-10-08 | Prolinx, Inc. | Phenyldiboronic acid reagents and complexes |
| US6075126A (en) * | 1996-08-05 | 2000-06-13 | Prolinx, Inc. | Phenyldiboronic acid reagents and complexes |
| US6124471A (en) * | 1996-08-05 | 2000-09-26 | Prolinx, Inc. | Phenyldiboronic acid reagents and complexes |
| US6449562B1 (en) * | 1996-10-10 | 2002-09-10 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
| US6146833A (en) * | 1997-02-11 | 2000-11-14 | Beckman Coulter, Inc. | Polymeric reagents for immobilizing biopolymers |
| US6139800A (en) * | 1997-06-23 | 2000-10-31 | Luminex Corporation | Interlaced lasers for multiple fluorescence measurement |
| US6632526B1 (en) * | 1997-10-14 | 2003-10-14 | Luminex Corporation | Precision fluorescently dyed particles and methods of making and using same |
| US6514295B1 (en) * | 1997-10-14 | 2003-02-04 | Luminex Corporation | Precision fluorescently dyed particles and methods of making and using same |
| US20030028981A1 (en) * | 1997-10-14 | 2003-02-13 | Chandler Don J. | Precision fluorescently dyed particles and methods of making and using same |
| US6268222B1 (en) * | 1998-01-22 | 2001-07-31 | Luminex Corporation | Microparticles attached to nanoparticles labeled with flourescent dye |
| US6411904B1 (en) * | 1998-05-14 | 2002-06-25 | Luminex Corporation | Zero dead time architecture for flow cytometer |
| US6366354B1 (en) * | 1998-05-14 | 2002-04-02 | Luminex Corporation | Diode laser based measurement apparatus |
| US6046807A (en) * | 1998-05-14 | 2000-04-04 | Luminex Corporation | Diode laser based measurement apparatus |
| US6656876B1 (en) * | 1998-10-16 | 2003-12-02 | Amersham Biosciences Ab | Squaric acid activated carrier usable for immobilization of compounds containing amine groups |
| US20040087032A1 (en) * | 1999-08-17 | 2004-05-06 | Chandler Mark B. | Microparticles with multiple fluorescent signals and methods of using same |
| US20040039201A1 (en) * | 2001-11-14 | 2004-02-26 | Lugade Ananda G. | Functionalized compositions for improved immobilization |
| US20050118199A1 (en) * | 2003-10-07 | 2005-06-02 | Esser Mark T. | Process for covalently conjugating polysaccharides to microspheres or biomolecules |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10155051B2 (en) | 2008-08-13 | 2018-12-18 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| WO2010019718A3 (en) * | 2008-08-13 | 2010-05-27 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| US8557292B2 (en) | 2008-08-13 | 2013-10-15 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| US8746999B2 (en) | 2008-08-13 | 2014-06-10 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| US8968714B2 (en) | 2008-08-13 | 2015-03-03 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| US9186327B2 (en) | 2008-08-13 | 2015-11-17 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| US9334367B2 (en) | 2008-08-13 | 2016-05-10 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| US10342879B2 (en) | 2008-08-13 | 2019-07-09 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| US9913911B2 (en) | 2008-08-13 | 2018-03-13 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| US9610355B2 (en) | 2008-08-13 | 2017-04-04 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| US20100040556A1 (en) * | 2008-08-13 | 2010-02-18 | Davis Mark E | Carrier nanoparticles and related compositions, methods and systems |
| US10166291B2 (en) | 2013-03-01 | 2019-01-01 | California Institute Of Technology | Targeted nanoparticles |
| US11285212B2 (en) | 2013-03-01 | 2022-03-29 | California Institute Of Technology | Targeted nanoparticles |
| US20160146802A1 (en) * | 2014-11-20 | 2016-05-26 | General Electric Company | Porous membranes with a polymer grafting, methods and uses thereof |
| US11754563B2 (en) * | 2014-11-20 | 2023-09-12 | Global Life Sciences Solutions Operations UK Ltd | Porous membranes with a polymer grafting, methods and uses thereof |
| US10717825B2 (en) | 2015-07-01 | 2020-07-21 | California Instite of Technology | Cationic mucic acid polymer-based delivery system |
| US11041050B2 (en) | 2015-07-01 | 2021-06-22 | California Institute Of Technology | Cationic mucic acid polymer-based delivery systems |
| US11998616B2 (en) | 2018-06-13 | 2024-06-04 | California Institute Of Technology | Nanoparticles for crossing the blood brain barrier and methods of treatment using the same |
| CN109946453A (en) * | 2019-04-02 | 2019-06-28 | 珠海丽珠试剂股份有限公司 | A kind of coupling method of proliferating cell nuclear antigen |
| US11738092B2 (en) | 2019-12-04 | 2023-08-29 | Dantari, Inc. | Methods and compositions for synthesis of therapeutic nanoparticles |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006044275A3 (en) | 2007-04-26 |
| CN101044403B (en) | 2012-10-31 |
| KR20070085341A (en) | 2007-08-27 |
| US20110086431A1 (en) | 2011-04-14 |
| EP1802973A2 (en) | 2007-07-04 |
| JP4988578B2 (en) | 2012-08-01 |
| US7867774B2 (en) | 2011-01-11 |
| US8153440B2 (en) | 2012-04-10 |
| KR101230020B1 (en) | 2013-02-05 |
| ATE467127T1 (en) | 2010-05-15 |
| WO2006044275A2 (en) | 2006-04-27 |
| DE602005021135D1 (en) | 2010-06-17 |
| CA2583474C (en) | 2013-12-03 |
| EP1802973B1 (en) | 2010-05-05 |
| JP2008516240A (en) | 2008-05-15 |
| CA2583474A1 (en) | 2006-04-27 |
| CN101044403A (en) | 2007-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8153440B2 (en) | Methods for altering surface characteristics of microspheres | |
| JP3543001B2 (en) | Method for labeling or detecting substances using luminescent aryl sulfonate cyanine dye | |
| US5569587A (en) | Method for labeling and detecting materials employing luminescent arysulfonate cyanine dyes | |
| EP1476753B1 (en) | Functionalized compositions for improved immobilization | |
| US8361169B2 (en) | Methods for forming dyed microspheres and populations of dyed microspheres | |
| Riegler et al. | A facile method for coding and labeling assays on polystyrene beads with differently colored luminescent nanocrystals | |
| Dinga et al. | High brightness red emitting polymer beads for immunoassays: Comparison between trifluoroacetylacetonates of Europium | |
| JP4581571B2 (en) | Quantitative method for measuring the amount of maleimidyl groups in particles | |
| HK1114172A (en) | Methods for altering surface characteristics of microspheres |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: LUMINEX CORPORATION, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LUGADE, ANANDA G.;HOFFACKER, KURT D.;REEL/FRAME:017095/0816 Effective date: 20051006 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| CC | Certificate of correction | ||
| FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| CC | Certificate of correction | ||
| FPAY | Fee payment |
Year of fee payment: 4 |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552) Year of fee payment: 8 |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |